View in EDS

AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.

Saved in:
Bibliographic Details
Title: AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
Authors: Sakemura RL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Hefazi M; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Cox MJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Siegler EL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Sinha S; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Hansen MJ; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Stewart CM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Feigin JM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Manriquez Roman C; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Schick KJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Can I; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Tapper EE; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Horvei P; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Adada MM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Bezerra ED; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Kankeu Fonkoua LA; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Ruff MW; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Forsman CL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Nevala WK; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Boysen JC; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Tschumper RC; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Grand CL; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Kuchimanchi KR; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Mouritsen L; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Foulks JM; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Warner SL; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Call TG; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Ding W; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kay NE; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kenderian SS; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.
Source: Cancer immunology research [Cancer Immunol Res] 2023 Sep 01; Vol. 11 (9), pp. 1222-1236.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37378662
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sakemura+RL%22">Sakemura RL</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Hefazi+M%22">Hefazi M</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Cox+MJ%22">Cox MJ</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Siegler+EL%22">Siegler EL</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Sinha+S%22">Sinha S</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Hansen+MJ%22">Hansen MJ</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Stewart+CM%22">Stewart CM</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Feigin+JM%22">Feigin JM</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Manriquez+Roman+C%22">Manriquez Roman C</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Schick+KJ%22">Schick KJ</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Can+I%22">Can I</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Tapper+EE%22">Tapper EE</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Horvei+P%22">Horvei P</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Adada+MM%22">Adada MM</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Bezerra+ED%22">Bezerra ED</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Kankeu+Fonkoua+LA%22">Kankeu Fonkoua LA</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Ruff+MW%22">Ruff MW</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Department of Neurology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Forsman+CL%22">Forsman CL</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Nevala+WK%22">Nevala WK</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Boysen+JC%22">Boysen JC</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Tschumper+RC%22">Tschumper RC</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Grand+CL%22">Grand CL</searchLink>; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah.<br /><searchLink fieldCode="AU" term="%22Kuchimanchi+KR%22">Kuchimanchi KR</searchLink>; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah.<br /><searchLink fieldCode="AU" term="%22Mouritsen+L%22">Mouritsen L</searchLink>; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah.<br /><searchLink fieldCode="AU" term="%22Foulks+JM%22">Foulks JM</searchLink>; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah.<br /><searchLink fieldCode="AU" term="%22Warner+SL%22">Warner SL</searchLink>; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah.<br /><searchLink fieldCode="AU" term="%22Call+TG%22">Call TG</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Parikh+SA%22">Parikh SA</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Ding+W%22">Ding W</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Kay+NE%22">Kay NE</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Kenderian+SS%22">Kenderian SS</searchLink>; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2023 Sep 01; Vol. 11 (9), pp. 1222-1236.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37378662
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-22-0254
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1222
    Titles:
      – TitleFull: AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sakemura RL
      – PersonEntity:
          Name:
            NameFull: Hefazi M
      – PersonEntity:
          Name:
            NameFull: Cox MJ
      – PersonEntity:
          Name:
            NameFull: Siegler EL
      – PersonEntity:
          Name:
            NameFull: Sinha S
      – PersonEntity:
          Name:
            NameFull: Hansen MJ
      – PersonEntity:
          Name:
            NameFull: Stewart CM
      – PersonEntity:
          Name:
            NameFull: Feigin JM
      – PersonEntity:
          Name:
            NameFull: Manriquez Roman C
      – PersonEntity:
          Name:
            NameFull: Schick KJ
      – PersonEntity:
          Name:
            NameFull: Can I
      – PersonEntity:
          Name:
            NameFull: Tapper EE
      – PersonEntity:
          Name:
            NameFull: Horvei P
      – PersonEntity:
          Name:
            NameFull: Adada MM
      – PersonEntity:
          Name:
            NameFull: Bezerra ED
      – PersonEntity:
          Name:
            NameFull: Kankeu Fonkoua LA
      – PersonEntity:
          Name:
            NameFull: Ruff MW
      – PersonEntity:
          Name:
            NameFull: Forsman CL
      – PersonEntity:
          Name:
            NameFull: Nevala WK
      – PersonEntity:
          Name:
            NameFull: Boysen JC
      – PersonEntity:
          Name:
            NameFull: Tschumper RC
      – PersonEntity:
          Name:
            NameFull: Grand CL
      – PersonEntity:
          Name:
            NameFull: Kuchimanchi KR
      – PersonEntity:
          Name:
            NameFull: Mouritsen L
      – PersonEntity:
          Name:
            NameFull: Foulks JM
      – PersonEntity:
          Name:
            NameFull: Warner SL
      – PersonEntity:
          Name:
            NameFull: Call TG
      – PersonEntity:
          Name:
            NameFull: Parikh SA
      – PersonEntity:
          Name:
            NameFull: Ding W
      – PersonEntity:
          Name:
            NameFull: Kay NE
      – PersonEntity:
          Name:
            NameFull: Kenderian SS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1